Effects of Pioglitazone and rosiglitazone on blood lipid levels and glycemic control in patients with type 2 diabetes mellitus: A retrospective review of randomly selected medical records
References (53)
- et al.
Thiazolidine-diones: An update
Lancet
(2000) - et al.
Medical significance of peroxisome proliferator-activated receptors
Lancet
(1999) - et al.
Pioglitazone hydrochloride in combination with sulfonylurea therapy improves glycemic control in patients with type 2 diabetes mellitus: A randomized, placebo-controlled study
Am J Med
(2001) - et al.
Pioglitazone hydrochloride in combination with metformin in the treatment of type 2 diabetes mellitus: A randomized, placebo-controlled study
Clin Ther
(2000) - et al.
Comparison of effects of thiazolidinediones on cardiovascular risk factors: Observations from a clinical practice
Endocr Pract.
(2001) - et al.
Hypertriglyceridemia as a cardiovascular risk factor
Am J Cardiol
(1998) - et al.
Heart disease in diabetes mellitus
Endocrinol Metab Clin North Am
(1996) - et al.
VLDL activation of plasminogen activator inhibitor-1 (PAI-1) expression: Involvement of the VLDL receptor
J Lipid Res
(1999) - et al.
Thiazolidinediones down-regulate plasminogen activator inhibitor type 1 expression in human vascular endothelial cells: A possible role for PPARgamma in endothelial function
Biochem Biophys Res Commun
(1999) - et al.
Nonhypoglycemic effects of thiazolidinediones
Ann Intern Med.
(2001)
Treatment of insulin resistance with peroxisome proliferator-activated receptor gamma agonists
J Clin Invest
Hepatic dysfunction associated with troglitazone
N Engl J Med
An autopsy case of troglitazone-induced fulminant hepatitis
Diabetes Care
Two cases of severe clinical and histologic hepatotoxicity associated with troglitazone
Ann Intern Med
Thiazolidinediones for type 2 diabetes. No evidence exists that pioglitazone induces hepatic cytochrome P450 isoform CYP3A4
Br Med J
Hepatocellular injury in a patient receiving pioglitazone
Ann Intern Med
Hepatocellular injury in a patient receiving rosiglitazone. A case report
Ann Intern Med
Hepatic failure in a patient taking rosiglitazone
Ann Intern Med
Rosiglitazone and hepatic failure
Ann Intern Med
Rosiglitazone and liver failure
Ann Intern Med
Rosiglitazone toxicity
Ann Intern Med
The impact of pioglitazone on glycemic control and atherogenic dyslipidemia in patients with type 2 diabetes mellitus
Coron Artery Dis
Pioglitazone hydrochloride monotherapy improves glycemic control in the treatment of patients with type 2 diabetes: A 6-month randomized placebo-controlled dose-response study
Diabetes Care
Rosiglitazone monotherapy is effective in patients with type 2 diabetes
J Clin Endocrinol Metab
Cited by (165)
Dietary supplementation with pioglitazone hydrochloride and L-carnosine improves the growth performance, muscle fatty acid profiles and shelf life of yellow-feathered broiler chickens
2021, Animal NutritionCitation Excerpt :Excessive abdominal fat content can negatively affect feed efficiency and carcass performance. The abdominal fat yield decreased with PGZ supplementation, which was more beneficial for IMF deposition (Boyle et al., 2002; Cai et al., 2011). Unlike abdominal fat, IMF is a favorable trait of great economic importance and has a positive effect on the tenderness, flavor, and juiciness of meat (Bonny et al., 2015; Gerbens et al., 2001).
Effect of the acute and chronic administration of Lupinus albus β-conglutin on glycaemia, circulating cholesterol, and genes potentially involved
2021, Biomedicine and PharmacotherapyCitation Excerpt :Besides, serum triglyceride levels decreased, whereas total serum cholesterol increased. El-Batran et al. reported that rosiglitazone lowered cholesterol and triglyceride levels in rats induced to diabetes by STZ [44], our results, however, agree with those observed in patients treated with rosiglitazone [45]. Nonetheless, our findings should be interpreted with caution since the effects of rosiglitazone are dose-dependent [46].
Rational design and synthesis of some PPAR-γ agonists: Substituted benzylideneamino-benzylidene-thiazolidine-2,4-diones
2017, Computational Biology and ChemistryIdentifying plausible adverse drug reactions using knowledge extracted from the literature
2014, Journal of Biomedical InformaticsSynthesis, characterization and biological evaluation of some novel 2,4-thiazolidinediones as potential cytotoxic, antimicrobial and antihyperglycemic agents
2012, Bioorganic and Medicinal Chemistry LettersEffect of rosiglitazone on circulating malondialdehyde (MDA) level in diabetes based on a systematic review and meta-analysis of eight clinical trials
2021, Journal of Investigative Medicine